$HALB Spotlight! *Secured license to two issued p
Post# of 7008
(Total Views: 54)
Posted On: 10/12/2020 11:47:13 AM
$HALB Spotlight!
*Secured license to two issued patents on an extracorporeal treatment process, previously held by Premier Biomedical.
*Established Coronavirus as clinical target for extracorporeal patent application.
*Secured license to three provisional patent applications for Coronavirus work.
*Secured required non-dilutive funding to start work at a research facility.
*Conducted and completed a search for an ideal university partner, selecting a world-class organization with outstanding research personnel.
*Began working with our university partner on September 1, 2020, and established bi-weekly technology review meetings to track progress and guide research direction as needed.
*Recently acquired license to a fourth provisional patent application targeting coronavirus prevention and treatment.
*Developed a unique antibody that conjoins Covid disease antigens and has exceeded expectations in testing.
http://www.thestreetnow.com/spotlight/halb/
*Secured license to two issued patents on an extracorporeal treatment process, previously held by Premier Biomedical.
*Established Coronavirus as clinical target for extracorporeal patent application.
*Secured license to three provisional patent applications for Coronavirus work.
*Secured required non-dilutive funding to start work at a research facility.
*Conducted and completed a search for an ideal university partner, selecting a world-class organization with outstanding research personnel.
*Began working with our university partner on September 1, 2020, and established bi-weekly technology review meetings to track progress and guide research direction as needed.
*Recently acquired license to a fourth provisional patent application targeting coronavirus prevention and treatment.
*Developed a unique antibody that conjoins Covid disease antigens and has exceeded expectations in testing.
http://www.thestreetnow.com/spotlight/halb/
(0)
(0)Scroll down for more posts ▼